Hologic Inc
NASDAQ:HOLX

Watchlist Manager
Hologic Inc Logo
Hologic Inc
NASDAQ:HOLX
Watchlist
Price: 79 USD -0.92% Market Closed
Market Cap: 18.3B USD
Have any thoughts about
Hologic Inc?
Write Note

Operating Margin
Hologic Inc

24.1%
Current
30%
Average
4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
24.1%
=
Operating Profit
970.2m
/
Revenue
4B

Operating Margin Across Competitors

Country US
Market Cap 18.3B USD
Operating Margin
24%
Country US
Market Cap 205.2B USD
Operating Margin
17%
Country US
Market Cap 193.1B USD
Operating Margin
26%
Country US
Market Cap 148.6B USD
Operating Margin
22%
Country US
Market Cap 132.9B USD
Operating Margin
18%
Country IE
Market Cap 109.9B USD
Operating Margin
19%
Country US
Market Cap 64.8B USD
Operating Margin
14%
Country DE
Market Cap 56.7B EUR
Operating Margin
12%
Country CN
Market Cap 325.5B CNY
Operating Margin
36%
Country US
Market Cap 42.2B USD
Operating Margin
28%
Country US
Market Cap 37.7B USD
Operating Margin
13%
No Stocks Found

Hologic Inc
Glance View

Market Cap
18.3B USD
Industry
Health Care
Economic Moat
None

Hologic Inc. is a leading global medical technology company dedicated to improving women's health through innovative diagnostics, medical imaging, and surgical products. Founded in 1982, Hologic has carved out a niche in the healthcare sector, specifically focusing on areas such as breast health, cervical health, and skeletal health. The company’s flagship products include advanced breast imaging systems and molecular diagnostics, which enable early disease detection and improve patient outcomes. As awareness and demand for women's health services continue to grow, Hologic stands out as a key player, consistently investing in research and development to stay at the forefront of medical innovation. For investors, Hologic represents a promising opportunity with its robust portfolio and strategic positioning in expanding markets. The company has experienced significant growth, driven by its commitment to addressing critical health issues, particularly in breast cancer screening and gynecological diagnostics. With a track record of strong financial performance and a resilient business model, Hologic is poised to benefit from tailwinds in healthcare spending and increasing emphasis on preventive care. As societal shifts continue to favor healthcare advancements that prioritize women's health, Hologic's consistent revenue growth and strategic acquisitions create a compelling case for investment, establishing it as a company well equipped to thrive in an evolving marketplace.

HOLX Intrinsic Value
82.29 USD
Undervaluation 4%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
24.1%
=
Operating Profit
970.2m
/
Revenue
4B
What is the Operating Margin of Hologic Inc?

Based on Hologic Inc's most recent financial statements, the company has Operating Margin of 24.1%.